Reju Stem Cells celebrates four years of growth, advancing regenerative medicine with a focus on transparency, patient ...

Adia Nutrition, Inc. (OTCQB: ADIA), a publicly traded company focused on regenerative medicine, stem cell therapies, and biologic products, today announced that it is in the process of changing its ...

Regenerative medicine is renowned for its potential to restore or replace damaged or diseased organs by harnessing stem cells. The power of regenerative medicine will be especially valuable for ...

It is common for regenerative medicine to require workflows and techniques that combine many different experimental approaches. 2 Regenerative medicine does this by gathering information from all of ...

Integrant (INGT) awarded Nasdaq ticker ahead IPO, advancing AI-driven regenerative medicine and orthopaedic therapies from ...

Dr. Don Buford, founder of Texas Orthobiologics in Dallas, Texas, has been named Chairman of the Biologic Association for the 2026?2027 term, beginning at the organization's annual meeting May 17 in ...

BioLamina’s core innovation lies in its proprietary laminins—highly specialized proteins that replicate the natural environment in which human cells grow.

In August 2006 Professor Yamanaka Shin’ya of Kyoto University published a paper reporting his success in producing induced pluripotent stem cells, and in a 2014 clinical study, tissue derived from iPS ...

UCB (Euronext Brussels: UCB), a global biopharmaceutical company, today announced that it has entered into a definitive agreement under which UCB would acquire Neurona Therapeutics, including lead ...

The FDA granted regenerative medicine advanced therapy designation to RTx-015 for the treatment of retinitis pigmentosa.

Rise in prevalence of chronic diseases and surge in geriatric population are the major factors that drive the growth of the regenerative medicine market. However, high costs of treatment hinder the ...